# Two Way Bioequivalence Study Under Fed Conditions

> **NCT01217801** · PHASE1 · COMPLETED · sponsor: **MonoSol Rx** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ondansetron (ODFS)
- **DRUG:** Ondansetron (ODT)

## Key facts

- **NCT ID:** NCT01217801
- **Lead sponsor:** MonoSol Rx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01217801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01217801, "Two Way Bioequivalence Study Under Fed Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01217801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*